BrightPath Biotherapeutics Co., Ltd.
TSE:4594.T
87 (JPY) • At close September 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 810.47 | 1,057.36 | 1,530.969 | 2,305.026 | 3,265.388 | 3,018.356 | 4,901.177 | 6,528.759 | 4,950.57 | 2,555.458 | 823.737 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 810.47 | 1,057.36 | 1,530.969 | 2,305.026 | 3,265.388 | 3,018.356 | 4,901.177 | 6,528.759 | 4,950.57 | 2,555.458 | 823.737 |
| Net Receivables
| 64.679 | 0.006 | 0.055 | 16.586 | 0.283 | 0.659 | 0.841 | 104.767 | 54.944 | 118.161 | 102.244 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27.569 | 42.31 | 36.239 | 148.5 |
| Other Current Assets
| 196.166 | 123.594 | 120.186 | 374.438 | 385.321 | 309.171 | 259.629 | 252.467 | 191.645 | 81.5 | 81.498 |
| Total Current Assets
| 1,071.315 | 1,180.96 | 1,651.21 | 2,696.05 | 3,650.992 | 3,328.186 | 5,161.647 | 6,900.127 | 5,239.469 | 2,791.358 | 1,155.979 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 0 | 0 | 0 | 24.918 | 48.201 | 97.156 | 90.76 | 266.349 | 115.872 | 48.521 | 45.255 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.514 | 13.789 | 11.255 | 2.157 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.514 | 13.789 | 11.255 | 2.157 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55 | 39 | 26.116 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -55 | -39 | -26.116 | 0 |
| Other Non-Current Assets
| 49.297 | 49.296 | 50.234 | 50.234 | 50.234 | 49.296 | 52.055 | 55.912 | 39.17 | 26.117 | 24.074 |
| Total Non-Current Assets
| 49.297 | 49.296 | 50.234 | 75.152 | 98.435 | 146.452 | 142.815 | 335.775 | 168.831 | 85.893 | 71.486 |
| Total Assets
| 1,120.612 | 1,230.257 | 1,701.444 | 2,771.202 | 3,749.428 | 3,474.639 | 5,304.463 | 7,235.902 | 5,408.3 | 2,877.251 | 1,227.465 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 0.035 | 0.02 | 0.077 | 1.912 | 0.468 | 0.814 | 28.333 | 8.769 | 22.554 | 96.23 | 103.076 |
| Short Term Debt
| 25 | 112.5 | 0 | 87.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 12.815 | 10.409 | 38.817 | 31.998 | 34.158 | 31.92 | 35.041 | 24.689 | 10.487 | 4.531 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.361 | 0 |
| Other Current Liabilities
| 106.626 | 65.676 | 66.072 | 56.426 | 123.939 | 137.89 | 88.563 | 185.297 | 114.025 | 22.18 | 71.303 |
| Total Current Liabilities
| 131.661 | 191.011 | 76.558 | 184.655 | 156.405 | 172.862 | 148.816 | 229.107 | 161.268 | 128.897 | 178.91 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 4.819 | 4.7 | 4.11 | 1.715 | 2.076 |
| Other Non-Current Liabilities
| 63.962 | 60.258 | 57.347 | 55.073 | 55.381 | 66.54 | 54.757 | 51.525 | 41.773 | 25.976 | 22.352 |
| Total Non-Current Liabilities
| 63.962 | 60.26 | 57.347 | 55.073 | 55.381 | 66.54 | 59.576 | 56.225 | 45.883 | 27.691 | 24.428 |
| Total Liabilities
| 195.623 | 251.271 | 133.905 | 239.728 | 211.786 | 239.402 | 208.392 | 285.332 | 207.151 | 156.588 | 203.338 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 1,199.869 | 650.661 | 362.185 | 6,700.382 | 6,459.712 | 5,433.211 | 5,427.836 | 5,419.931 | 3,774.413 | 1,988.085 | 642.585 |
| Retained Earnings
| -3,804.864 | -2,653.715 | -1,485.633 | -10,875.815 | -9,391.623 | -7,671.989 | -5,814.215 | -3,929.896 | -2,352.753 | -1,239.092 | -244.627 |
| Accumulated Other Comprehensive Income/Loss
| 21.58 | 22.845 | 20.268 | 22.94 | 26.257 | 57.219 | 71.029 | 57.019 | 20.216 | 0 | 0 |
| Other Total Stockholders Equity
| 3,508.402 | 2,959.195 | 2,670.719 | 6,683.967 | 6,443.296 | 5,416.796 | 5,482.45 | 5,403.516 | 3,757.999 | 1,971.67 | 749.211 |
| Total Shareholders Equity
| 924.987 | 978.986 | 1,567.539 | 2,531.474 | 3,537.642 | 3,235.237 | 5,096.071 | 6,950.57 | 5,199.875 | 2,720.663 | 1,024.127 |
| Total Equity
| 924.987 | 978.986 | 1,567.539 | 2,531.474 | 3,537.642 | 3,235.237 | 5,096.071 | 6,950.57 | 5,201.149 | 2,720.663 | 1,024.127 |
| Total Liabilities & Shareholders Equity
| 1,120.612 | 1,230.257 | 1,701.444 | 2,771.202 | 3,749.428 | 3,474.639 | 5,304.463 | 7,235.902 | 5,408.3 | 2,877.251 | 1,227.465 |